GRFS

Grifols SA GRFS

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$7.52B

Quarter to Dec 31

Net income

$402.00M

Quarter to Dec 31

Free cash flow

$782.00M

Quarter to Dec 31

Operating margin

16.5%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$1.01B total
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

About Grifols SA (GRFS): stock profile, AI score and financials

Grifols SA (GRFS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GRFS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), Grifols SA reports quarterly revenue of $7.5B, net income of $402.0M, an operating margin of 16.5%. GRFS trades on the Nasdaq exchange and files with the SEC under CIK 1438569. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GRFS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Grifols SA directly from SEC EDGAR.

SEC EDGAR: CIK 1438569 →